Lenvatinib Plus Paclitaxel for Patients With Advanced Biliary Tract Cancer Who Failed to Gemcitabine-based Treatment
Clinical trial NCT05170438 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05170438
- Sponsor
- National Health Research Institutes, Taiwan
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-01
- Primary completion
- 2028-06-01
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.